ArticleItalian journal of pediatrics2025

Estimated impact of nirsevimab prophylaxis on the economic burden of respiratory syncytial virus disease in Northern Italy.

Chryssoula Tzialla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.